Genetic risk factor clustering within and across neurodegenerative diseases
Mathew J. Koretsky(National Institutes of Health), Hampton L. Leonard(National Institutes of Health), Sara Bandrés‐Ciga(National Institutes of Health), Sonja W. Scholz(School of the Art Institute of Chicago), Faraz Faghri(National Institute of Neurological Disorders and Stroke), Cornelis Blauwendraat(National Institutes of Health), Lana Sargent(National Institutes of Health), Dan Vitale(National Institutes of Health), Anant Dadu(National Institutes of Health), Hirotaka Iwaki(National Institute of Neurological Disorders and Stroke), Andrew Singleton(Laboratory of Molecular Genetics), Mary B. Makarious(National Institutes of Health), Kristin Levine(National Institutes of Health), Mike A. Nalls(Alzheimer's Association), Chelsea X. Alvarado(National Institutes of Health)
Cited by 32
Related Papers
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
|New England Journal of Medicine|2009|2.1k
Genome-wide association study reveals genetic risk underlying Parkinson's disease
|Nature Genetics|2009|2k
The Parkinson Progression Marker Initiative (PPMI)
|Progress in Neurobiology|2011|1.9k